Tourette syndrome and other tic disorders

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 641-657

  Singer, Harvey S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; BOOK; GILLES DE LA TOURETTE SYNDROME; HISTORY; HUMAN; TIC;

HISTORY, 19TH CENTURY; HUMANS; MODELS, BIOLOGICAL; TIC DISORDERS; TOURETTE SYNDROME;

EID: 79954515858     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00046-X     Document Type: Book

References (224)

1. Abelson J.F., Kwan K.Y., O'Roak B.J., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
2. Abuzzahab F.S., Brown V.L. Control of Tourette's syndrome with topiramate. Am J Psychiatry 2001, 158:968.
3. Ackermans L., Temel Y., Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome. Neurotherapeutics 2008, 5:339-344.
4. Albin R.L., Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci 2006, 29:175-182.
5. Albin R.L., Koeppe R.A., Bohnen N.I., et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61:310-315.
6. Allen R.P., Singer H.S., Brown J.E., et al. Sleep disorders in Tourette syndrome: a primary or unrelated problem?. Pediatr Neurol 1992, 8:275-280.
7. Alsobrook J.P., Pauls D.L. A factor analysis of tic symptoms in Gilles de la Tourette's syndrome. Am J Psychiatry 2002, 159:291-296.
8. Altman G., Staley J.D., Wener P. Children with Tourette disorder: a follow-up study in adulthood. J Nerv Ment Dis 2009, 197:305-310.
9. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th Edn.
10. Anca M.H., Giladi N., Korczyn A.D. Ropinirole in Gilles de la Tourette syndrome. Neurology 2004, 62:1626-1627.
11. Apter A., Pauls D.L., Bleich A., et al. An epidemiologic study of Gilles de la Tourette's syndrome in Israel. Arch Gen Psychiatry 1993, 50:734-738.
12. Awaad Y., Michon A.M., Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005, 20:714-718.
13. Banaschewski T., Woerner W., Rothenberger A. Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol 2003, 45:700-703.
14. Baron-Cohen S., Mortimore C., Moriarty J., et al. The prevalence of Gilles de la Tourette's syndrome in children and adolescents with autism. J Child Psychol Psychiatry 1999, 40:213-218.
15. Baxter L.R., Schwartz J.M., Guze B.H., et al. PET imaging in obsessive compulsive disorder with and without depression. J Clin Psychiatry 1990, 51:61-69. discussion 70.
16. Beard G.M. Experiments with the " jumpers" or " jumping" Frenchmen of Maine. J Nerv Ment Dis 1886, 7:487-490.
17. Behen M., Chugani H.T., Juhasz C., et al. Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome. Mov Disord 2007, 22:2256-2262.
18. Berardelli A., Curra A., Fabbrini G., et al. Pathophysiology of tics and Tourette syndrome. J Neurol 2003, 250:781-787.
19. Bergin A., Waranch H.R., Brown J., et al. Relaxation therapy in Tourette syndrome: a pilot study. Pediatr Neurol 1998, 18:136-142.
20. Bloch M.H., Leckman J.F., Zhu H., et al. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253-1258.
21. Bloch M.H., Sukhodolsky D.G., Leckman J.F., et al. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. J Child Psychol Psychiatry 2006, 47:551-559.
22. Bombaci M., Grifantini R., Mora M., et al. Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against group A streptococcus antigens. PLoS ONE 2009, 4:e6332.
23. Budman C.L., Gayer A., Lesser M., et al. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 2001, 62:290-294.
24. Budman C.L., Rockmore L., Stokes J., et al. Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 2003, 55:59-65.
25. Burd L., Severud R., Klug M.G., et al. Prenatal and perinatal risk factors for Tourette disorder. J Perinat Med 1999, 27:295-302.
26. Canales J.J., Graybiel A.M. Patterns of gene expression and behavior induced by chronic dopamine treatments. Ann Neurol 2000, 47:S53-S59.
27. Cavanna A.E., Robertson M.M., Critchley H.D. Schizotypal personality traits in Gilles de la Tourette syndrome. Acta Neurol Scand 2007, 116:385-391.
28. Cavanna A.E., Robertson M.M., Critchley H.D. Catatonic signs in Gilles de la Tourette syndrome. Cogn Behav Neurol 2008, 21:34-37.
29. Cavanna A.E., Schrag A., Morley D., et al. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. Neurology 2008, 71:1410-1416.
30. Cerullo J., Reimschisel T., Singer H. Genetic and neurobiological basis for Tourette syndrome. Treating Tourette Syndrome and Tic Disorders: A Guide for Practitioners 2007, Vol. 1. Guilford Press, New York, NY.
31. Channon S., Pratt P., Robertson M.M. Executive function, memory, and learning in Tourette's syndrome. Neuropsychology 2003, 17:247-254.
32. Chemali Z., Bromfield E. Tourette's syndrome following temporal lobectomy for seizure control. Epilepsy Behav 2003, 4:564-566.
33. Church A.J., Dale R.C., Lees A.J., et al. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003, 74:602-607.
34. Coffey B.J., Park K.S. Behavioral and emotional aspects of Tourette syndrome. Neurol Clin 1997, 15:277-289.
35. Coffey B.J., Biederman J., Geller D.A., et al. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000, 39:556-561.
36. Cohrs S., Rasch T., Altmeyer S., et al. Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry 2001, 70:192-197.
37. Comings D.E., Comings B.G.A. controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987, 41:701-741.
38. Comings D.E., Himes J.A., Comings B.G. An epidemiologic study of Tourette's syndrome in a single school district. J Clin Psychiatry 1990, 51:463-469.
39. Cooper C., Robertson M.M., Livingston G. Psychological morbidity and caregiver burden in parents of children with Tourette's disorder and psychiatric comorbidity. J Am Acad Child Adolesc Psychiatry 2003, 42:1370-1375.
40. Copur M., Arpaci B., Demir T., et al. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome: a retrospective case-note survey. Clin Drug Investig 2007, 27:123-130.
41. Cubo E., Gonzalez M., Singer H., et al. Impact of placebo assignment in clinical trials of tic disorders. Mov Disord 2008, 23:S146.
42. Dale R.C., Candler P.M., Church A.J., et al. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2005, 172:187-197.
43. Deckersbach T., Rauch S., Buhlmann U., et al. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther 2006, 44:1079-1090.
44. Deng H., Le W.D., Xie W.J., et al. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand 2006, 6:400-402.
45. Devinsky O. Neuroanatomy of Gilles de la Tourette's syndrome. Possible midbrain involvement. Arch Neurol 1983, 40:508-514.
46. Dion Y., Annable L., Sandor P., et al. Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31-39.
47. Eapen V., O'Neill J., Gurling H.M., et al. Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 1997, 48:934-937.
48. Eapen V., Lees A., Lakke J., et al. Adult-onset tic disorders. Mov Disord 2002, 17:735-740.
49. Erenberg G., Cruse R.P., Rothner A.D. Tourette syndrome: an analysis of 200 pediatric and adolescent cases. Cleve Clin Q 1986, 53:127-131.
50. Erenberg G., Cruse R.P., Rothner A.D. The natural history of Tourette syndrome: a follow-up study. Ann Neurol 1987, 22:383-385.
51. Erer S., Jankovic J. Adult onset tics after peripheral injury. Parkinsonism Relat Disord 2008, 14:75-76.
52. Faraone S.V., Biederman J., Lehman B.K., et al. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol 1993, 102:616-623.
53. Findley D.B., Leckman J.F., Katsovich L., et al. Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents with Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2003, 42:450-457.
54. Fredericksen K.A., Cutting L.E., Kates W.R., et al. Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 2002, 58:85-89.
55. Freeman R.D. Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 2007, 16:15-23.
56. Furtado S., Suchowersky O. Investigation of the potential role of genetic imprinting in Gilles de la Tourette syndrome. Am J Med Genet 1994, 51:51-54.
57. Gabbay V., Coffey B.J., Babb J.S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics 2008, 122:273-278.
58. Gaffney G.R., Perry P.J., Lund B.C., et al. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330-336.
59. Garraux G., Goldfine A., Bohlhalter S., et al. Increased midbrain gray matter in Tourette's syndrome. Ann Neurol 2006, 59:381-385.
60. Ghanizadeh A., Mosallaei S. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome. Brain Dev 2009, 31:15-19.
61. Gilbert D.L., Dure L., Sethuraman G., et al. Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606-611.
62. Gilles de la Tourette G Étude sur une affection nerveuse caractérisée par l'incoordination motrice accompagnée d'écholalie et de copralalie. Arch Neurol 1885, 9:158-200.
63. Goldenberg J.N., Brown S.B., Weiner W.J. Coprolalia in younger patients with Gilles de la Tourette syndrome. Mov Disord 1994, 9:622-625.
64. Gomis M., Puente V., Pont-Sunyer C., et al. Adult onset simple phonic tic after caudate stroke. Mov Disord 2008, 23:765-766.
65. Gonce M., Barbeau A. Seven cases of Gilles de la Tourette's syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci 1977, 4:279-283.
66. Grados M.A., Mathews C.A. Latent class analysis of Gilles de la Tourette syndrome using comorbidities: clinical and genetic implications. Biol Psychiatry 2008, 64:219-225.
67. Hagin R., Kugler J. School Problems Associated with Tourette's Syndrome 1988, Wiley, New York.
68. Hall M., Costa D.C., Shields J. Brain perfusion patterns with 99Tcm -HMPAO/SPECT in patients with Gilles de la Tourette syndrome - short report. Nuclear Medicine: The State of the Art of Nuclear Medicine in Europe 1991, 243-245. Schattauer, Stuttgart. H.A.E. Schmidt, J.B. van der Schoot (Eds.).
69. Hammond W.A. Myriachit, a newly described disease of the nervous system and its analogues. New York Med J 1884, 39:191-192.
70. Hampson M., Tokoglu F., King R.A., et al. Brain areas coactivating with motor cortex during chronic motor tics and intentional movements. Biol Psychiatry 2009, 65:594-599.
71. Hanna P.A., Janjua F.N., Contant C.F., et al. Bilineal transmission in Tourette syndrome. Neurology 1999, 53:813-818.
72. Harris E.L., Schuerholz L.J., Singer H.S., et al. Executive function in children with Tourette syndrome and/or attention deficit hyperactivity disorder. J Int Neuropsychol Soc 1995, 1:511-516.
73. Harris K., Singer H.S. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurology 2006, 21:678-689.
74. Haugbol S., Pinborg L.H., Regeur L., et al. Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 2007, 10:245-252.
75. Hedderick E.F., Morris C.M., Singer H.S. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009, 40:420-425.
76. Hoekstra P., Steenhuis M., Kallenberg C., et al. Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: a prospective longitudinal study. J Clin Psychiatry 2004, 65:426-431.
77. Hoekstra P.J., Steenhuis M.P., Troost P.W., et al. Relative contribution of attention-deficit hyperactivity disorder, obsessive-compulsive disorder, and tic severity to social and behavioral problems in tic disorders. J Dev Behav Pediatr 2004, 25:272-279.
78. Hoekstra P.J., Anderson G.M., Limburg P.C., et al. Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci 2004, 61:886-898.
79. Huckeba W., Chapieski L., Hiscock M., et al. Arithmetic performance in children with Tourette syndrome: relative contribution of cognitive and attentional factors. J Clin Exp Neuropsychol 2008, 30:410-420.
80. Hyde T.M., Aaronson B.A., Randolph C., et al. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 1992, 42:652-658.
81. Jankovic J., Ashikawa T. Tourettism associated with Huntington's disease. Mov Disord 1995, 10:103-105.
82. Jankovic J., Kwak C., Frankoff R. Tourette's syndrome and the law. J Neuropsychiatry Clin Neurosci 2006, 18:86-95.
83. Jeffries K.J., Schooler C., Schoenbach C., et al. The functional neuroanatomy of Tourette's syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology 2002, 27:92-104.
84. Kates W.R., Frederiksen M., Mostofsky S.H., et al. MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res 2002, 116:63-81.
85. Kenney C.J., Hunter C.B., Mejia N.I., et al. Tetrabenazine in the treatment of Tourette syndrome. J Pediatr Neurol 2007, 5:9-13.
86. Khalifa N., von Knorring A.L. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 2003, 45:315-319.
87. Kirov R., Kinkelbur J., Banaschewski T., et al. Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity. J Child Psychol Psychiatry 2007, 48:561-570.
88. Klawans H.L., Falk D.K., Nausieda P.A., et al. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology 1978, 28:1064-1066.
89. Kompoliti K., Goetz C.G. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord 1998, 13:477-480.
90. Ko S., Ahn T., Kim J., et al. A case of adult onset tic disorder following carbon monoxide intoxication. Can J Neurol Sci 2004, 31:268-270.
91. Kostanecka-Endress T., Banaschewski T., Kinkelbur J., et al. Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res 2003, 55:23-29.
92. Krauss J., Jankovic J. Tics secondary to craniocerebral trauma. Mov Disord 1997, 12:776-782.
93. Kurlan R. The PANDAS hypothesis: losing its bite?. Mov Disord 2004, 19:371-374.
94. Kurlan R., Kaplan E.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004, 113:883-886.
95. Kurlan R., Whitmore D., Irvine C., et al. Tourette's syndrome in a special education population: a pilot study involving a single school district. Neurology 1994, 44:699-702.
96. Kurlan R., McDermott M.P., Deeley C., et al. Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001, 57:1383-1388.
97. Kurlan R., Como P.G., Miller B., et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 2002, 59:414-420.
98. Kurlan R., Johnson D., Kaplan E.L. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008, 121:1188-1197.
99. Kwak C., Dat Vuong K., Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003, 18:1530-1533.
100. Kwak C.H., Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord 2002, 17:821-825.
101. Kwak C.H., Hanna P.A., Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190-1193.
102. Leckman J.F., Riddle M.A., Hardin M.T., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989, 28:566-573.
103. Leckman J.F., Walker D.E., Cohen D.J. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993, 150:98-102.
104. Leckman J.F., Zhang H., Vitale A., et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998, 102:14-19.
105. Leckman J.F., Katsovich L., Kawikova I., et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 2005, 57:667-673.
106. Leonard H.L., Swedo S.E., Rapoport J.L., et al. Tourette syndrome and obsessive-compulsive disorder. Adv Neurol 1992, 58:83-93.
107. Lerner A., Bagic A., Boudreau E.A., et al. Neuroimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 2007, 68:1979-1987.
108. Lesperance P., Djerroud N., Diaz Anzaldua A., et al. Restless legs in Tourette syndrome. Mov Disord 2004, 19:1084-1087.
109. Lichter D.G., Dmochowski J., Jackson L.A., et al. Influence of family history on clinical expression of Tourette's syndrome. Neurology 1999, 52:308-316.
110. Lombroso P.J., Scahill L.D., Chappell P.B., et al. Tourette's syndrome: a multigenerational, neuropsychiatric disorder. Adv Neurol 1995, 65:305-318.
111. Luo F., Leckman J.F., Katsovich L., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004, 113:e578-e585.
112. Majumdar A., Appleton R.E. Delayed and severe but transient Tourette syndrome after head injury. Pediatr Neurol 2002, 27:314-317.
113. Mantovani A., Leckman J.F., Grantz H., et al. Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases. Clin Neurophysiol 2007, 118:2314-2315.
114. Marras C., Andrews D., Sime E., et al. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56:605-610.
115. Martino D., Defazio G., Church A.J., et al. Antineuronal antibody status and phenotype analysis in Tourette's syndrome. Mov Disord 2007, 22:1424-1429.
116. Martino D., Draganski B., Cavanna A., et al. Anti-basal ganglia antibodies and Tourette's syndrome: a voxel-based morphometry and diffusion tensor imaging study in an adult population. J Neurol Neurosurg Psychiatry 2008, 79:820-822.
117. Martino D., Dale R.C., Gilbert D.L., et al. Immunopathogenic mechanisms in Tourette syndrome: A critical review. Mov Disord 2009, 24:1267-1279.
118. Mason A., Banerjee S., Eapen V., et al. The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 1998, 40:292-296.
119. Mathews C.A., Waller J., Glidden D., et al. Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neurosurg Psychiatry 2004, 75:1149-1155.
120. Mathews C.A., Bimson B., Lowe T.L., et al. Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry 2006, 163:1066-1073.
121. Mathews C.A., Jang K.L., Herrera L.D., et al. Tic symptom profiles in subjects with Tourette syndrome from two genetically isolated populations. Biol Psychiatry 2007, 61:292-300.
122. McCracken J.T., Suddath R., Chang S., et al. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol 2008, 18:501-508.
123. McMahon W., Carter A.S., Fredine N., et al. Children at familial risk for Tourette's disorder: Child and parent diagnoses. Am J Med Genet 2003, 121B:105-111.
124. Mell L.K., Davis R.L., Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005, 116:56-60.
125. Mink J.W. Clinical review of DBS for Tourette syndrome. Front Biosci (Elite Ed) 2009, 1:72-76.
126. Mink J.W., Thach W.T. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993, 3:950-957.
127. Mink J.W., Walkup J., Frey K.A., et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006, 21:1831-1838.
128. Minzer K., Lee O., Hong J.J., et al. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum. J Neurol Sci 2004, 219:55-61.
129. Moll G.H., Wischer S., Heinrich H., et al. Deficient motor control in children with tic disorder: evidence from transcranial magnetic stimulation. Neurosci Lett 1999, 272:37-40.
130. Moriarty J., Varma A.R., Stevens J., et al. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997, 49:410-415.
131. Morris C.M., Pardo-Villamizar C., Gause C.D., et al. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 2009, 276:45-48.
132. Mukaddes N.M., Abali O. Quetiapine treatment of children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 2003, 13:295-299.
133. Muller-Vahl K.R., Kaufmann J., Grosskreutz J., et al. Prefrontal and anterior cingulate cortex abnormalities in Tourette syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci 2009, 10:47.
134. Munchau A., Bloem B.R., Thilo K.V., et al. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology 2002, 59:1789-1791.
135. Murphy T.K., Snider L.A., Mutch P.J., et al. Relationship of movements and behaviors to group A streptococcus infections in elementary school children. Biol Psychiatry 2007, 61:279-284.
136. Northam R.S., Singer H.S. Postencephalitic acquired Tourette-like syndrome in a child. Neurology 1991, 41:592-593.
137. O'Brien J.A. Latah. J Br Asiat Soc 1883, 1:381-429.
138. O'Connor K., Brisebois H., Brault M., et al. Behavioral activity associated with onset in chronic tic and habit disorder. Behav Res Therapy 2003, 41:241-249.
139. Orth M., Kirby R., Richardson M.P., et al. Subthreshold rtms over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin Neurophysiol 2005, 116:764-768.
140. Pappert E.J., Goetz C.G., Louis E.D., et al. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 2003, 61:936-940.
141. Pauls D.L., Leckman J.F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 1986, 315:993-997.
142. Pauls D.L., Raymond C.L., Stevenson J.M., et al. A family study of Gilles de la Tourette syndrome. Am J Hum Genet 1991, 48:154-163.
143. Pauls D.L., Leckman J.F., Cohen D.J. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 1993, 32:1044-1050.
144. Pauls D.L., Leckman J.F., Cohen D.J. Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorders. Br J Psychiatry 1994, 164:215-221.
145. Pavone P., Bianchini R., Parano E., et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004, 30:107-110.
146. Perrin E.M., Murphy M.L., Casey J.R., et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?. Arch Pediatr Adolesc Med 2004, 158:848-856.
147. Peterson B.S., Leckman J.F. The temporal dynamics of tics in Gilles de la Tourette syndrome. Biol Psychiatry 1998, 44:1337-1348.
148. Peterson B.S., Skudlarski P., Anderson A.W., et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998, 55:326-333.
149. Peterson B.S., Staib L., Scahill L., et al. Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001, 58:427-440.
150. Peterson B.S., Thomas P., Kane M.J., et al. Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003, 60:415-424.
151. Pigott T.A., L'Heureux F., Dubbert B., et al. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry 1994, 55:15-27. discussion 28-32.
152. Pollard M., Gause C.D., Morris C.M., et al. Serum Antibody Reactivity against Tubulin is not Altered in Children with PANDAS and Tourette Syndrome 2009, Child Neurology Society, Louisville.
153. Porta M., Sassi M., Cavallazzi M., et al. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig 2008, 28:443-459.
154. Price R.A., Kidd K.K., Cohen D.J., et al. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985, 42:815-820.
155. Pringsheim T., Lang A., Kurlan R., et al. Understanding disability in Tourette syndrome. Dev Med Child Neurol 2009, 51:468-472.
156. Rickards H., Robertson M. A controlled study of psychopathology and associated symptoms in Tourette syndrome. World J Biol Psychiatry 2003, 4:64-68.
157. Riddle M.A., Rasmusson A.M., Woods S.W., et al. SPECT imaging of cerebral blood flow in Tourette syndrome. Adv Neurol 1992, 58:207-211.
158. Riedel M., Straube A., Schwarz M.J., et al. Lyme disease presenting as Tourette's syndrome. Lancet 1998, 351:418-419.
159. Robertson M., Yakeley J. Obsessive-compulsive and self injurious behavior 1993, Marcel Dekker, New York.
160. Robertson M.M. The relationship between Gilles de la Tourette's syndrome and obsessive compulsive disorder. Journal of Serotonin Res 1995, 1:49-62.
161. Robertson M.M. Diagnosing Tourette syndrome: is it a common disorder?. J Psychosom Res 2003, 55:3-6.
162. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008, 65:461-472.
163. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes. J Psychosom Res 2008, 65:473-486.
164. Robertson M.M., Stern J.S. Tic disorders: new developments in Tourette syndrome and related disorders. Curr Opin Neurol 1998, 11:373-380.
165. Robertson M.M., Trimble M.R., Lees A.J. The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis. Br J Psychiatry 1988, 152:383-390.
166. Robertson M.M., Banerjee S., Hiley P.J., et al. Personality disorder and psychopathology in Tourette's syndrome: a controlled study. Br J Psychiatry 1997, 171:283-286.
167. Romstad A., Dupont E., Krag-Olsen B., et al. Dopa-responsive dystonia and Tourette syndrome in a large Danish family. Arch Neurol 2003, 60:618-622.
168. Rosenberg L.A., Brown J., Singer H.S. Self-reporting of behavior problems in patients with tic disorders. Psychol Rep 1994, 74:653-654.
169. Sallee F.R., Kurlan R., Goetz C.G., et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292-299.
170. Sallee F.R., Gilbert D.L., Vinks A.A., et al. Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. J Am Acad Child Adolesc Psychiatry 2003, 42:902-907.
171. Scahill L., Chappell P.B., Kim Y.S., et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067-1074.
172. Scahill L., Leckman J.F., Schultz R.T., et al. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130-1135.
173. Scahill L., Erenberg G., Berlin C.M., et al. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 2006, 3:192-206.
174. Scarano V., Pellecchia M., Filla A., et al. Hallervorden-Spatz syndrome resembling a typical Tourette syndrome. Mov Disord 2002, 17:618-620.
175. Schneider S.A., Robertson M.M., Rizzo R., et al. Fragile X syndrome associated with tic disorders. Mov Disord 2008, 23:1108-1112.
176. Schuerholz L.J., Baumgardner T.L., Singer H.S., et al. Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder. Neurology 1996, 46:958-965.
177. Schuerholz L.J., Singer H.S., Denckla M.B. Gender study of neuropsychological and neuromotor function in children with Tourette syndrome with and without attention-deficit hyperactivity disorder. J Child Neurol 1998, 13:277-282.
178. Seo W.S., Sung H.M., Sea H.S., et al. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. J Child Adolesc Psychopharmacol 2008, 18:197-205.
179. Serra-Mestres J., Ring H.A., Costa D.C., et al. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Acta Psychiatr Scand 2004, 109:140-146.
180. Servello D., Porta M., Sassi M., et al. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008, 79:136-142.
181. Seuchter S.A., Hebebrand J., Klug B., et al. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genet Epidemiol 2000, 18:33-47.
182. Seymour B., O'Doherty J.P., Dayan P., et al. Temporal difference models describe higher-order learning in humans. Nature 2004, 429:664-667.
183. Shprecher D., Kurlan R. The management of tics. Mov Disord 2009, 24:15-24.
184. Singer H., Mink J., Hallett J., et al. Is the microinfusion of antineuronal antibodies into rodent striatum a valid method to evalutate autoimmunity in pediatric movement disorders?. Ann Neurol 2004, 56:S89.
185. Singer H.S. Tics and Tourette syndrome. Johns Hopkins Med J 1982, 151:30-35.
186. Singer H.S. Discussing outcome in Tourette syndrome. Arch Pediatr Adolesc Med 2006, 160:103-105.
187. Singer H.S., Minzer K. Neurobiology of Tourette syndrome: concepts of neuroanatomical localization and neurochemical abnormalities. Brain Dev 2003, 25:S70-S84.
188. Singer H.S., Rosenberg L.A. Development of behavioral and emotional problems in Tourette syndrome. Pediatr Neurol 1989, 5:41-44.
189. Singer H.S., Hahn I.H., Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 1991, 30:558-562.
190. Singer H.S., Reiss A.L., Brown J.E., et al. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome. Neurology 1993, 43:950-956.
191. Singer H.S., Schuerholz L.J., Denckla M.B. Learning difficulties in children with Tourette syndrome. J Child Neurol 1995, 10:S58-S61.
192. Singer H.S., Dickson J., Martinie D., et al. Second messenger systems in Tourette's syndrome. J Neurol Sci 1995, 128:78-83.
193. Singer H.S., Dela Cruz P.S., Abrams M.T., et al. A Tourette-like syndrome following cardiopulmonary bypass and hypothermia: MRI volumetric measurements. Mov Disord 1997, 12:588-592.
194. Singer H.S., Wendlandt J., Krieger M., et al. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001, 56:599-604.
195. Singer H.S., Szymanski S., Giuliano J., et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 2002, 159:1329-1336.
196. Singer H.S., Hong J.J., Yoon D.Y., et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65:1701-1707.
197. Singer H.S., Gause C., Morris C., et al. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008, 121:1198-1205.
198. Singer W.D. Transient Gilles de la Tourette syndrome after chronic neuroleptic withdrawal. Dev Med Child Neurol 1981, 23:518-521.
199. Smith-Hicks C.L., Bridges D.D., Paynter N.P., et al. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007, 22:1764-1770.
200. Snider L.A., Swedo S.E. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol 2003, 16:359-365.
201. Spencer T.J., Biederman J., Faraone S., et al. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry 2001, 158:611-617.
202. Stephens R.J., Bassel C., Sandor P. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome - a pilot study. J Child Adolesc Psychopharmacol 2004, 14:255-266.
203. Stern E., Silbersweig D.A., Chee K.Y., et al. A functional neuroanatomy of tics in Tourette syndrome. Arch Gen Psychiatry 2000, 57:741-748.
204. Storch E.A., Merlo L.J., Lack C., et al. Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol 2007, 36:217-227.
205. Sukhodolsky D.G., Scahill L., Zhang H., et al. Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry 2003, 42:98-105.
206. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264-271.
207. The Tourette Syndrome Association International Consortium for Genetics Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007, 80:265-272.
208. The Tourette Syndrome Classification Study Group Definitions and classification of tic disorders. Arch Neurol 1993, 50:1013-1016.
209. Thompson W.W., Price C., Goodson B., et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007, 357:1281-1292.
210. Vincent D.A. Botulinum toxin in the management of laryngeal tics. J Voice 2008, 22:251-256.
211. Walkup J.T., LaBuda M.C., Singer H.S., et al. Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. Am J Hum Genet 1996, 59:684-693.
212. Wilhelm S., Deckersbach T., Coffey B.J., et al. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry 2003, 160:1175-1177.
213. Wolf S.S., Jones D.W., Knable M.B., et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996, 273:1225-1227.
214. Wong D., Brasic J., Kuwabara H., et al. Abnormalities of dopamine and serotonin neuroreceptors with PET in Tourette syndrome 2005, Program no. 1012.15.2005., Society for Neuroscience, Washington, DC.
215. Wong D.F., Singer H.S., Brandt J., et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997, 38:1243-1247.
216. Wong D.F., Brasic J.R., Singer H.S., et al. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 2008, 33:1239-1251.
217. Wood B.L., Klebba K., Gbadebo O., et al. Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome. Mov Disord 2003, 18:1392-1395.
218. Woods D.W., Twohig M.P., Flessner C.A., et al. Treatment of vocal tics in children with Tourette syndrome: investigating the efficacy of habit reversal. J Appl Behav Anal 2003, 36:109-112.
219. Woods D.W., Piacentini J.C., Chang S.W., et al. Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults 2008, Oxford University Press, New York.
220. Wu L., Li H., Kang L. 156 cases of Gilles de la Tourette's syndrome treated by acupuncture. J Tradit Chin Med 1996, 16:211-213.
221. Yochelson M.R., David R.G. New-onset tic disorder following acute hemorrhage of an arteriovenous malformation. J Child Neurol 2000, 15:769-771.
222. Yoo H.K., Kim J.Y., Kim C.Y. A pilot study of aripiprazole in children and adolescents with Tourette's disorder. J Child Adolesc Psychopharmacol 2006, 16:505-506.
223. Yoon D.Y., Gause C.D., Leckman J.F., et al. Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis. J Neurol Sci 2007, 255:50-56.
224. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997, 154:1277-1284.